We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

87 hedge funds and large institutions have $230M invested in Abeona Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $2.29M | Put options by funds: $732K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.11% less ownership

Funds ownership: 2.72% → 2.61% (-0.11%)

1% less capital invested

Capital invested by funds: $232M → $230M (-$2.3M)

12% less funds holding

Funds holding: 99 → 87 (-12)

26% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 31

75% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 16

Holders
87
Holders Change
-12
Holders Change %
-12.12%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
23
Reduced
31
Closed
16
Calls
$2.29M
Puts
$732K
Net Calls
+$1.56M
Net Calls Change
+$1.02M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.95M
2
Millennium Management
Millennium Management
New York
+$1.89M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.04M
4
OM
Opaleye Management
Massachusetts
+$787K
5
BlackRock
BlackRock
New York
+$716K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$5.83M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$2.1M
3
SFM
Sphera Funds Management
Israel
-$1.93M
4
Citigroup
Citigroup
New York
-$1.27M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$537K – – –
Charles Schwab
27
Charles Schwab
California
$505K +$7.33K +41 +2%
CT
28
Cambridge Trust
Massachusetts
$481K – – –
Morgan Stanley
29
Morgan Stanley
New York
$438K -$78.7K -440 -16%
TCIM
30
TIAA CREF Investment Management
New York
$433K -$3.93K -22 -0.9%
EGM
31
Engineers Gate Manager
New York
$431K -$328K -1,832 -44%
AllianceBernstein
32
AllianceBernstein
Tennessee
$421K – – –
CBFP
33
Cedar Brook Financial Partners
Ohio
$405K – – –
Goldman Sachs
34
Goldman Sachs
New York
$392K +$76.5K +428 +25%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$383K -$40.8K -228 -10%
BGIM
36
Brandywine Global Investment Management
Pennsylvania
$369K -$43.4K -243 -11%
Swiss National Bank
37
Swiss National Bank
Switzerland
$369K – – –
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$358K – – –
MWNA
39
Marshall Wace North America
New York
$353K -$64.2K -359 -16%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$339K – – –
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$310K +$69.4K +388 +30%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$299K -$7.69K -43 -3%
Nisa Investment Advisors
43
Nisa Investment Advisors
Missouri
$277K +$71.5K +400 +36%
VEA
44
Virtus ETF Advisers
New York
$261K -$32.5K -182 -11%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$243K – – –
CIM
46
CIM Investment Management
Pennsylvania
$236K -$1.97K -11 -0.9%
SG Americas Securities
47
SG Americas Securities
New York
$230K +$61K +341 +38%
AAP
48
Ardsley Advisory Partners
Connecticut
$221K +$80.6K +451 +60%
CS
49
Credit Suisse
Switzerland
$205K -$66.9K -374 -25%
HFM
50
Hartford Financial Management
Connecticut
$193K +$2.15K +12 +1%
1
2
3 4 5

ABEO Hedge Fund Activity: Q1 2019 in Review

87 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2019, worth a combined $230M — down 0.99% from $232M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ABEO and 4 opened new positions — a net loss of 12 holders — while 31 trimmed existing stakes and 23 added.

The largest buyer was Vanguard Group, adding an estimated $2.95M. The largest seller was Baker Bros. Advisors, cutting an estimated $5.83M.

  • 87 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2019, down from 99 in Q4 2018.
  • Funds reported $230M of Abeona Therapeutics stock for Q1 2019, down 0.99% quarter-over-quarter.
  • 4 funds opened new Abeona Therapeutics positions in Q1 2019 and 16 closed out, a net change of -12 holders.
  • The largest Abeona Therapeutics buyer in Q1 2019 was Vanguard Group, an estimated $2.95M added.
  • The largest Abeona Therapeutics seller in Q1 2019 was Baker Bros. Advisors, an estimated $5.83M sold.

Based on aggregated 13F filings for Q1 2019.